Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 7.63628801 |
2 | muscle filament sliding (GO:0030049) | 7.15247039 |
3 | actin-myosin filament sliding (GO:0033275) | 7.15247039 |
4 | plasma membrane repair (GO:0001778) | 6.83733498 |
5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.64105089 |
6 | cardiac myofibril assembly (GO:0055003) | 6.63520645 |
7 | regulation of skeletal muscle contraction (GO:0014819) | 6.51124595 |
8 | myofibril assembly (GO:0030239) | 6.45046899 |
9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.43561603 |
10 | actin-mediated cell contraction (GO:0070252) | 6.00209509 |
11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.97212257 |
12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.90531446 |
13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.80929842 |
14 | cardiac muscle contraction (GO:0060048) | 5.43166350 |
15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.34314464 |
16 | actomyosin structure organization (GO:0031032) | 5.09268615 |
17 | cardiac muscle cell development (GO:0055013) | 5.02616152 |
18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.00476340 |
19 | striated muscle contraction (GO:0006941) | 4.98288270 |
20 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.95382094 |
21 | carnitine shuttle (GO:0006853) | 4.88002847 |
22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.80190960 |
23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.76667876 |
24 | cardiac cell development (GO:0055006) | 4.75459168 |
25 | regulation of cell communication by electrical coupling (GO:0010649) | 4.70289325 |
26 | regulation of relaxation of muscle (GO:1901077) | 4.70193008 |
27 | tricarboxylic acid cycle (GO:0006099) | 4.70190493 |
28 | actin filament-based movement (GO:0030048) | 4.69503984 |
29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.68003987 |
30 | regulation of actin filament-based movement (GO:1903115) | 4.64542239 |
31 | skeletal muscle contraction (GO:0003009) | 4.54055952 |
32 | cell communication involved in cardiac conduction (GO:0086065) | 4.31612835 |
33 | adult heart development (GO:0007512) | 4.29258876 |
34 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.24014247 |
35 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.22674573 |
36 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.21431061 |
37 | response to muscle activity (GO:0014850) | 4.20706659 |
38 | skeletal muscle adaptation (GO:0043501) | 4.17941264 |
39 | cardiac muscle hypertrophy (GO:0003300) | 4.17895511 |
40 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.13901511 |
41 | fatty acid transmembrane transport (GO:1902001) | 4.13598428 |
42 | regulation of membrane repolarization (GO:0060306) | 4.09949910 |
43 | striated muscle hypertrophy (GO:0014897) | 4.05999324 |
44 | regulation of striated muscle contraction (GO:0006942) | 3.98528504 |
45 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.97312979 |
46 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.88882829 |
47 | muscle tissue morphogenesis (GO:0060415) | 3.83945283 |
48 | desmosome organization (GO:0002934) | 3.82985503 |
49 | skeletal muscle fiber development (GO:0048741) | 3.81966644 |
50 | myotube cell development (GO:0014904) | 3.80444462 |
51 | cell communication by electrical coupling (GO:0010644) | 3.74600578 |
52 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.73541438 |
53 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.68539064 |
54 | muscle contraction (GO:0006936) | 3.65667927 |
55 | heart trabecula formation (GO:0060347) | 3.64873657 |
56 | regulation of sarcomere organization (GO:0060297) | 3.63365036 |
57 | carnitine transmembrane transport (GO:1902603) | 3.61934156 |
58 | cardiac muscle cell action potential (GO:0086001) | 3.59130009 |
59 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.57456171 |
60 | regulation of coenzyme metabolic process (GO:0051196) | 3.55914646 |
61 | regulation of cofactor metabolic process (GO:0051193) | 3.55914646 |
62 | muscle hypertrophy (GO:0014896) | 3.46218866 |
63 | regulation of the force of heart contraction (GO:0002026) | 3.45421633 |
64 | creatine metabolic process (GO:0006600) | 3.39423563 |
65 | amino-acid betaine transport (GO:0015838) | 3.38742056 |
66 | carnitine transport (GO:0015879) | 3.38742056 |
67 | response to inactivity (GO:0014854) | 3.37916533 |
68 | striated muscle cell development (GO:0055002) | 3.37376975 |
69 | striated muscle adaptation (GO:0014888) | 3.35083773 |
70 | muscle system process (GO:0003012) | 3.34545037 |
71 | negative regulation of potassium ion transport (GO:0043267) | 3.34008554 |
72 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.31554523 |
73 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.31554523 |
74 | striated muscle atrophy (GO:0014891) | 3.29265191 |
75 | regulation of heart rate (GO:0002027) | 3.28320630 |
76 | cardiac conduction (GO:0061337) | 3.26996222 |
77 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.23066406 |
78 | skeletal muscle tissue development (GO:0007519) | 3.21204178 |
79 | relaxation of cardiac muscle (GO:0055119) | 3.20230329 |
80 | positive regulation of cation channel activity (GO:2001259) | 3.18427493 |
81 | muscle atrophy (GO:0014889) | 3.14899699 |
82 | muscle fiber development (GO:0048747) | 3.13394532 |
83 | regulation of cardiac muscle contraction (GO:0055117) | 3.12261253 |
84 | muscle cell cellular homeostasis (GO:0046716) | 3.12206160 |
85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.09668433 |
86 | NADH metabolic process (GO:0006734) | 3.08786371 |
87 | heart contraction (GO:0060047) | 3.08071693 |
88 | heart process (GO:0003015) | 3.08071693 |
89 | glycogen catabolic process (GO:0005980) | 3.05243129 |
90 | cardiac muscle adaptation (GO:0014887) | 3.02618219 |
91 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.02618219 |
92 | muscle hypertrophy in response to stress (GO:0003299) | 3.02618219 |
93 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.99442265 |
94 | regulation of cardioblast differentiation (GO:0051890) | 2.99305728 |
95 | regulation of heart contraction (GO:0008016) | 2.99159112 |
96 | myoblast fusion (GO:0007520) | 2.98852509 |
97 | positive regulation of heart contraction (GO:0045823) | 2.95243845 |
98 | detection of calcium ion (GO:0005513) | 2.94151384 |
99 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93999541 |
100 | response to caffeine (GO:0031000) | 2.93749107 |
101 | regulation of sulfur metabolic process (GO:0042762) | 2.93477203 |
102 | muscle cell development (GO:0055001) | 2.91271499 |
103 | negative regulation of protein localization to cell surface (GO:2000009) | 2.89018819 |
104 | positive regulation of heart rate (GO:0010460) | 2.88166066 |
105 | glucan catabolic process (GO:0009251) | 2.85815020 |
106 | regulation of sequestering of triglyceride (GO:0010889) | 2.84308278 |
107 | regulation of ATP catabolic process (GO:1903289) | 2.83682336 |
108 | regulation of ATPase activity (GO:0043462) | 2.83682336 |
109 | positive regulation of sodium ion transport (GO:0010765) | 2.77606765 |
110 | muscle structure development (GO:0061061) | 2.77180138 |
111 | muscle organ development (GO:0007517) | 2.75024021 |
112 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.74400902 |
113 | muscle adaptation (GO:0043500) | 2.71942830 |
114 | myotube differentiation (GO:0014902) | 2.67021058 |
115 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.66363445 |
116 | muscle cell fate commitment (GO:0042693) | 2.65689350 |
117 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.64514191 |
118 | regulation of muscle system process (GO:0090257) | 2.63796107 |
119 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.60024981 |
120 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.60024981 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.40399342 |
2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.10041552 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.09734891 |
4 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.92703064 |
5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.73921083 |
6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.72183679 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63025244 |
8 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.62578140 |
9 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.62578140 |
10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.57014781 |
11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11196884 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10489532 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04350203 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99007988 |
15 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.86126533 |
16 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85165706 |
17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82680305 |
18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80593927 |
19 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.75593652 |
20 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.74632824 |
21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73786720 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73213650 |
23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71628235 |
24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67685286 |
25 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66250904 |
26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62381702 |
27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.59440048 |
28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59251556 |
29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58029185 |
30 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56834610 |
31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53853067 |
32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49313899 |
33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.46759012 |
34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.46759012 |
35 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.46498812 |
36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.44001446 |
37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43522669 |
38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42684791 |
39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38602610 |
40 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38433870 |
41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37965054 |
42 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36111608 |
43 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.35733203 |
44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35663416 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33573097 |
46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33155077 |
47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30755312 |
48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30500649 |
49 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29030454 |
50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.28499436 |
51 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.28248545 |
52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.27674625 |
53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27123086 |
54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26761666 |
55 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.26552213 |
56 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25938293 |
57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24343241 |
58 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23261170 |
59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23226733 |
60 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22431477 |
61 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20719395 |
62 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20054275 |
63 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19176488 |
64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19093211 |
65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.18227433 |
66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17836896 |
67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17768683 |
68 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15593302 |
69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14679464 |
70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14223834 |
71 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14064865 |
72 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14040289 |
73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13988856 |
74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13950778 |
75 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13928988 |
76 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.13329657 |
77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13193390 |
78 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11719724 |
79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11667718 |
80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10905921 |
81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09580915 |
82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09567774 |
83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09446764 |
84 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08568233 |
85 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08387284 |
86 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.07516979 |
87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07256027 |
88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06422330 |
89 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05659088 |
90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04469566 |
91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04447157 |
92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03854085 |
93 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03843745 |
94 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02571515 |
95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02406176 |
96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02238925 |
97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02189499 |
98 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02178720 |
99 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01945102 |
100 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.01491394 |
101 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01490763 |
102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01252018 |
103 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01107684 |
104 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99988631 |
105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99957545 |
106 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99941224 |
107 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99750421 |
108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99521790 |
109 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99186814 |
110 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99171695 |
111 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98703375 |
112 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.98539536 |
113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98121236 |
114 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97761422 |
115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97323797 |
116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96854898 |
117 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96589024 |
118 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96546784 |
119 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96037841 |
120 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95414543 |
121 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94892699 |
122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94203072 |
123 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.93018006 |
124 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92487426 |
125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92415068 |
126 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91776211 |
127 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91505363 |
128 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90314853 |
129 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89711413 |
130 | * AR_19668381_ChIP-Seq_PC3_Human | 0.89592208 |
131 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89582702 |
132 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89281811 |
133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89000720 |
134 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88889799 |
135 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88735014 |
136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88385954 |
137 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87245036 |
138 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86744670 |
139 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86744670 |
140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86222405 |
141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85172585 |
142 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.85103516 |
143 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84600182 |
144 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84308889 |
145 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83673635 |
146 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82558909 |
147 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82558909 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.02029829 |
2 | MP0003646_muscle_fatigue | 5.49489863 |
3 | MP0000751_myopathy | 5.28967862 |
4 | MP0004084_abnormal_cardiac_muscle | 4.41955595 |
5 | MP0000749_muscle_degeneration | 4.07482973 |
6 | MP0004215_abnormal_myocardial_fiber | 3.76070405 |
7 | MP0004036_abnormal_muscle_relaxation | 3.75526678 |
8 | MP0004145_abnormal_muscle_electrophysio | 3.66481501 |
9 | MP0005330_cardiomyopathy | 3.16690314 |
10 | MP0004087_abnormal_muscle_fiber | 3.08476334 |
11 | MP0000750_abnormal_muscle_regeneration | 2.80748651 |
12 | MP0002106_abnormal_muscle_physiology | 2.73037927 |
13 | MP0005620_abnormal_muscle_contractility | 2.71354229 |
14 | MP0002269_muscular_atrophy | 2.58242083 |
15 | MP0004130_abnormal_muscle_cell | 2.56439606 |
16 | MP0000747_muscle_weakness | 2.53050581 |
17 | MP0002972_abnormal_cardiac_muscle | 2.52735815 |
18 | MP0000759_abnormal_skeletal_muscle | 2.36315009 |
19 | MP0003137_abnormal_impulse_conducting | 2.29107794 |
20 | MP0005369_muscle_phenotype | 2.29046839 |
21 | MP0004484_altered_response_of | 2.23550677 |
22 | MP0008775_abnormal_heart_ventricle | 2.19726583 |
23 | MP0010630_abnormal_cardiac_muscle | 2.16282790 |
24 | MP0004233_abnormal_muscle_weight | 2.07062165 |
25 | MP0001544_abnormal_cardiovascular_syste | 2.01096166 |
26 | MP0005385_cardiovascular_system_phenoty | 2.01096166 |
27 | MP0006138_congestive_heart_failure | 1.94758092 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.68674139 |
29 | MP0004085_abnormal_heartbeat | 1.67234929 |
30 | MP0005666_abnormal_adipose_tissue | 1.62258438 |
31 | MP0002234_abnormal_pharynx_morphology | 1.51625976 |
32 | MP0004185_abnormal_adipocyte_glucose | 1.48288351 |
33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46484642 |
34 | MP0002127_abnormal_cardiovascular_syste | 1.45767557 |
35 | MP0002332_abnormal_exercise_endurance | 1.38779887 |
36 | MP0003828_pulmonary_edema | 1.35256875 |
37 | MP0002108_abnormal_muscle_morphology | 1.33652505 |
38 | MP0005275_abnormal_skin_tensile | 1.29009591 |
39 | MP0005670_abnormal_white_adipose | 1.28948748 |
40 | MP0004510_myositis | 1.23071094 |
41 | MP0005375_adipose_tissue_phenotype | 1.17101530 |
42 | MP0003950_abnormal_plasma_membrane | 1.16722518 |
43 | MP0000733_abnormal_muscle_development | 1.14689875 |
44 | MP0002909_abnormal_adrenal_gland | 1.14155971 |
45 | MP0002822_catalepsy | 1.12753874 |
46 | MP0005451_abnormal_body_composition | 1.11640376 |
47 | MP0006036_abnormal_mitochondrial_physio | 1.11548364 |
48 | MP0005187_abnormal_penis_morphology | 1.05687425 |
49 | MP0000579_abnormal_nail_morphology | 1.02711820 |
50 | MP0001984_abnormal_olfaction | 1.02658841 |
51 | MP0000266_abnormal_heart_morphology | 1.01193367 |
52 | MP0008961_abnormal_basal_metabolism | 0.99956010 |
53 | MP0001661_extended_life_span | 0.96733879 |
54 | MP0009780_abnormal_chondrocyte_physiolo | 0.96448371 |
55 | MP0006276_abnormal_autonomic_nervous | 0.95349256 |
56 | MP0003566_abnormal_cell_adhesion | 0.95065919 |
57 | MP0005623_abnormal_meninges_morphology | 0.93672592 |
58 | MP0002876_abnormal_thyroid_physiology | 0.86344164 |
59 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86335904 |
60 | MP0000013_abnormal_adipose_tissue | 0.86095832 |
61 | MP0003879_abnormal_hair_cell | 0.84472326 |
62 | MP0002796_impaired_skin_barrier | 0.81770125 |
63 | MP0000566_synostosis | 0.81433336 |
64 | MP0000383_abnormal_hair_follicle | 0.79922648 |
65 | MP0003941_abnormal_skin_development | 0.77505930 |
66 | MP0004043_abnormal_pH_regulation | 0.77354798 |
67 | MP0004272_abnormal_basement_membrane | 0.76754970 |
68 | MP0010368_abnormal_lymphatic_system | 0.76594569 |
69 | MP0003283_abnormal_digestive_organ | 0.76539710 |
70 | MP0000003_abnormal_adipose_tissue | 0.75846937 |
71 | MP0003045_fibrosis | 0.71055549 |
72 | MP0002971_abnormal_brown_adipose | 0.68796137 |
73 | MP0005165_increased_susceptibility_to | 0.67728820 |
74 | MP0004270_analgesia | 0.66040930 |
75 | MP0001485_abnormal_pinna_reflex | 0.65876984 |
76 | MP0001299_abnormal_eye_distance/ | 0.65448529 |
77 | MP0005266_abnormal_metabolism | 0.65348889 |
78 | MP0000343_altered_response_to | 0.64862250 |
79 | MP0002638_abnormal_pupillary_reflex | 0.64845950 |
80 | MP0004858_abnormal_nervous_system | 0.64095413 |
81 | MP0002734_abnormal_mechanical_nocicepti | 0.62803722 |
82 | MP0005423_abnormal_somatic_nervous | 0.62771138 |
83 | MP0000762_abnormal_tongue_morphology | 0.62729058 |
84 | MP0010234_abnormal_vibrissa_follicle | 0.61297368 |
85 | MP0005083_abnormal_biliary_tract | 0.60196920 |
86 | MP0002128_abnormal_blood_circulation | 0.59970053 |
87 | MP0006035_abnormal_mitochondrial_morpho | 0.59621388 |
88 | MP0003279_aneurysm | 0.59084772 |
89 | MP0000230_abnormal_systemic_arterial | 0.58622627 |
90 | MP0002896_abnormal_bone_mineralization | 0.57241595 |
91 | MP0002653_abnormal_ependyma_morphology | 0.53287949 |
92 | MP0002272_abnormal_nervous_system | 0.53131461 |
93 | MP0004924_abnormal_behavior | 0.52624522 |
94 | MP0005386_behavior/neurological_phenoty | 0.52624522 |
95 | MP0001502_abnormal_circadian_rhythm | 0.51619598 |
96 | MP0008438_abnormal_cutaneous_collagen | 0.50483386 |
97 | MP0002925_abnormal_cardiovascular_devel | 0.49503183 |
98 | MP0010678_abnormal_skin_adnexa | 0.49366301 |
99 | MP0002078_abnormal_glucose_homeostasis | 0.48954097 |
100 | MP0003011_delayed_dark_adaptation | 0.48853272 |
101 | MP0005646_abnormal_pituitary_gland | 0.46948597 |
102 | MP0004859_abnormal_synaptic_plasticity | 0.46811063 |
103 | MP0001440_abnormal_grooming_behavior | 0.45214310 |
104 | MP0004142_abnormal_muscle_tone | 0.44835911 |
105 | MP0002249_abnormal_larynx_morphology | 0.44782935 |
106 | MP0009384_cardiac_valve_regurgitation | 0.44739309 |
107 | MP0001849_ear_inflammation | 0.44681713 |
108 | MP0005409_darkened_coat_color | 0.43927786 |
109 | MP0002877_abnormal_melanocyte_morpholog | 0.43095796 |
110 | MP0005551_abnormal_eye_electrophysiolog | 0.42177090 |
111 | MP0001486_abnormal_startle_reflex | 0.41940223 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.39948961 |
113 | MP0003385_abnormal_body_wall | 0.39570738 |
114 | MP0001784_abnormal_fluid_regulation | 0.38640723 |
115 | MP0008789_abnormal_olfactory_epithelium | 0.36815242 |
116 | MP0000767_abnormal_smooth_muscle | 0.36715219 |
117 | MP0009745_abnormal_behavioral_response | 0.36683999 |
118 | MP0008569_lethality_at_weaning | 0.36566737 |
119 | MP0005076_abnormal_cell_differentiation | 0.36521448 |
120 | MP0002184_abnormal_innervation | 0.36502083 |
121 | MP0004885_abnormal_endolymph | 0.36125846 |
122 | MP0009250_abnormal_appendicular_skeleto | 0.35490005 |
123 | MP0010030_abnormal_orbit_morphology | 0.33466562 |
124 | MP0003119_abnormal_digestive_system | 0.32328059 |
125 | MP0003935_abnormal_craniofacial_develop | 0.32241842 |
126 | MP0000467_abnormal_esophagus_morphology | 0.31889805 |
127 | MP0003948_abnormal_gas_homeostasis | 0.31247449 |
128 | MP0000537_abnormal_urethra_morphology | 0.31140005 |
129 | MP0006072_abnormal_retinal_apoptosis | 0.30762105 |
130 | MP0005503_abnormal_tendon_morphology | 0.30538588 |
131 | MP0005334_abnormal_fat_pad | 0.30506473 |
132 | MP0001879_abnormal_lymphatic_vessel | 0.30480270 |
133 | MP0000534_abnormal_ureter_morphology | 0.30129544 |
134 | MP0003984_embryonic_growth_retardation | 0.29526201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 6.72585058 |
2 | Exercise-induced myalgia (HP:0003738) | 6.62901641 |
3 | Exercise-induced muscle cramps (HP:0003710) | 6.15533184 |
4 | Calf muscle hypertrophy (HP:0008981) | 6.14316709 |
5 | Muscle fiber splitting (HP:0003555) | 5.96847983 |
6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.92496993 |
7 | Ventricular tachycardia (HP:0004756) | 5.52118367 |
8 | Hyporeflexia of lower limbs (HP:0002600) | 5.40201233 |
9 | Abnormality of the calf musculature (HP:0001430) | 5.05443224 |
10 | Muscle fiber inclusion bodies (HP:0100299) | 4.96599034 |
11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.85781033 |
12 | Right ventricular cardiomyopathy (HP:0011663) | 4.73798519 |
13 | Type 1 muscle fiber predominance (HP:0003803) | 4.73089232 |
14 | Increased connective tissue (HP:0009025) | 4.72430089 |
15 | Myoglobinuria (HP:0002913) | 4.68038162 |
16 | Difficulty running (HP:0009046) | 4.54819958 |
17 | Atrial fibrillation (HP:0005110) | 4.35721186 |
18 | EMG: myopathic abnormalities (HP:0003458) | 4.35676923 |
19 | Subaortic stenosis (HP:0001682) | 4.22733575 |
20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.22733575 |
21 | Nemaline bodies (HP:0003798) | 4.12490219 |
22 | Primary atrial arrhythmia (HP:0001692) | 4.10562604 |
23 | Supraventricular tachycardia (HP:0004755) | 3.91938961 |
24 | Lipoatrophy (HP:0100578) | 3.89101678 |
25 | Bundle branch block (HP:0011710) | 3.88527435 |
26 | Supraventricular arrhythmia (HP:0005115) | 3.86276807 |
27 | Myotonia (HP:0002486) | 3.76711396 |
28 | Syncope (HP:0001279) | 3.64160638 |
29 | Distal arthrogryposis (HP:0005684) | 3.50595005 |
30 | Difficulty climbing stairs (HP:0003551) | 3.50490930 |
31 | Rhabdomyolysis (HP:0003201) | 3.47531587 |
32 | Asymmetric septal hypertrophy (HP:0001670) | 3.39505134 |
33 | Prolonged QT interval (HP:0001657) | 3.29191724 |
34 | Dilated cardiomyopathy (HP:0001644) | 3.28151209 |
35 | Ventricular arrhythmia (HP:0004308) | 3.25061831 |
36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.22158709 |
37 | Myopathic facies (HP:0002058) | 3.15384146 |
38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.09343644 |
39 | Muscle stiffness (HP:0003552) | 3.05475906 |
40 | Palpitations (HP:0001962) | 3.04642315 |
41 | Ventricular fibrillation (HP:0001663) | 3.04600136 |
42 | Round ear (HP:0100830) | 3.04404243 |
43 | Heart block (HP:0012722) | 2.98357529 |
44 | Hypoplastic ischia (HP:0003175) | 2.93857720 |
45 | Abnormal atrioventricular conduction (HP:0005150) | 2.88637341 |
46 | Neck muscle weakness (HP:0000467) | 2.86188877 |
47 | Distal lower limb muscle weakness (HP:0009053) | 2.82528375 |
48 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.80337363 |
49 | Fetal akinesia sequence (HP:0001989) | 2.72787001 |
50 | Malignant hyperthermia (HP:0002047) | 2.69550751 |
51 | Atrioventricular block (HP:0001678) | 2.68119008 |
52 | Rimmed vacuoles (HP:0003805) | 2.64117475 |
53 | Areflexia of lower limbs (HP:0002522) | 2.60809667 |
54 | Ulnar deviation of the wrist (HP:0003049) | 2.59162331 |
55 | Abnormality of the ischium (HP:0003174) | 2.57594009 |
56 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.56177410 |
57 | Limb-girdle muscle atrophy (HP:0003797) | 2.51168469 |
58 | EMG: neuropathic changes (HP:0003445) | 2.49491345 |
59 | Abnormal EKG (HP:0003115) | 2.37665941 |
60 | Scapular winging (HP:0003691) | 2.31874557 |
61 | Bulbar palsy (HP:0001283) | 2.29394472 |
62 | Proximal amyotrophy (HP:0007126) | 2.28191527 |
63 | Ketoacidosis (HP:0001993) | 2.26547530 |
64 | Distal lower limb amyotrophy (HP:0008944) | 2.25756411 |
65 | Muscular dystrophy (HP:0003560) | 2.23811065 |
66 | Frequent falls (HP:0002359) | 2.17256092 |
67 | Hip contracture (HP:0003273) | 2.16213881 |
68 | Palmoplantar keratoderma (HP:0000982) | 2.14460999 |
69 | Testicular atrophy (HP:0000029) | 2.10849139 |
70 | Left ventricular hypertrophy (HP:0001712) | 2.10585983 |
71 | Spinal rigidity (HP:0003306) | 2.09713598 |
72 | Popliteal pterygium (HP:0009756) | 2.09303467 |
73 | Absent phalangeal crease (HP:0006109) | 2.04115728 |
74 | Generalized muscle weakness (HP:0003324) | 1.97633567 |
75 | Abnormality of the foot musculature (HP:0001436) | 1.96267857 |
76 | Limb-girdle muscle weakness (HP:0003325) | 1.95764172 |
77 | Dysmetric saccades (HP:0000641) | 1.95595795 |
78 | Waddling gait (HP:0002515) | 1.94223025 |
79 | Gowers sign (HP:0003391) | 1.91867435 |
80 | Foot dorsiflexor weakness (HP:0009027) | 1.91793157 |
81 | Weak cry (HP:0001612) | 1.91248748 |
82 | Facial diplegia (HP:0001349) | 1.89149960 |
83 | Hamartoma of the eye (HP:0010568) | 1.87787451 |
84 | Calcaneovalgus deformity (HP:0001848) | 1.86392103 |
85 | Lower limb amyotrophy (HP:0007210) | 1.81586340 |
86 | Nonprogressive disorder (HP:0003680) | 1.81289288 |
87 | Broad metatarsal (HP:0001783) | 1.81049773 |
88 | Hyperglycemia (HP:0003074) | 1.78078963 |
89 | Hyperkalemia (HP:0002153) | 1.77661425 |
90 | Conjunctival hamartoma (HP:0100780) | 1.76611606 |
91 | Abnormal ciliary motility (HP:0012262) | 1.76545144 |
92 | Aplasia of the musculature (HP:0100854) | 1.74406457 |
93 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.71592609 |
94 | Steppage gait (HP:0003376) | 1.71491357 |
95 | Absent/shortened dynein arms (HP:0200106) | 1.70768582 |
96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70768582 |
97 | Deformed tarsal bones (HP:0008119) | 1.67799994 |
98 | Abnormality of potassium homeostasis (HP:0011042) | 1.67246587 |
99 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.67203744 |
100 | Hypoglycemic coma (HP:0001325) | 1.66188266 |
101 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65744698 |
102 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.65744698 |
103 | Abnormality of the neuromuscular junction (HP:0003398) | 1.64850521 |
104 | Fatigable weakness (HP:0003473) | 1.64850521 |
105 | Large for gestational age (HP:0001520) | 1.64245140 |
106 | Abnormal finger flexion creases (HP:0006143) | 1.62729318 |
107 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.61652057 |
108 | Abnormality of the pubic bones (HP:0003172) | 1.61129175 |
109 | Limited hip movement (HP:0008800) | 1.60182793 |
110 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.59993672 |
111 | Lymphangioma (HP:0100764) | 1.56537991 |
112 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.56262041 |
113 | Shoulder girdle muscle weakness (HP:0003547) | 1.55932465 |
114 | Sudden cardiac death (HP:0001645) | 1.55252712 |
115 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.54797349 |
116 | Oligomenorrhea (HP:0000876) | 1.54008461 |
117 | Central scotoma (HP:0000603) | 1.52859203 |
118 | Rapidly progressive (HP:0003678) | 1.51964416 |
119 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.46805365 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 5.48573896 |
2 | OBSCN | 5.32252717 |
3 | PHKG1 | 4.23278551 |
4 | PHKG2 | 4.23278551 |
5 | TRIB3 | 2.84828419 |
6 | LMTK2 | 2.83247386 |
7 | DMPK | 2.69503498 |
8 | PDK3 | 2.43864966 |
9 | PDK4 | 2.43864966 |
10 | NEK1 | 2.37187712 |
11 | PKN2 | 2.12271651 |
12 | PINK1 | 1.96065591 |
13 | LATS1 | 1.94607218 |
14 | MYLK | 1.83098243 |
15 | PIK3CA | 1.77786477 |
16 | FRK | 1.74777427 |
17 | MUSK | 1.61254091 |
18 | ICK | 1.59553202 |
19 | LATS2 | 1.50516301 |
20 | NME1 | 1.49628239 |
21 | RIPK1 | 1.44389146 |
22 | BCKDK | 1.43519717 |
23 | MAP3K7 | 1.41410190 |
24 | PDK2 | 1.36612012 |
25 | PDGFRA | 1.35232258 |
26 | TIE1 | 1.29720506 |
27 | PAK3 | 1.28066561 |
28 | MAPK15 | 1.25781573 |
29 | MAPKAPK3 | 1.19330678 |
30 | STK24 | 1.13430548 |
31 | STK38L | 1.12629129 |
32 | STK38 | 1.07923485 |
33 | EPHA3 | 1.01718098 |
34 | PIK3CG | 0.99872287 |
35 | PRKAA1 | 0.98454669 |
36 | INSRR | 0.97928493 |
37 | PRKD1 | 0.97695303 |
38 | FER | 0.97041897 |
39 | MAP3K3 | 0.96833580 |
40 | AKT3 | 0.95040006 |
41 | CDC42BPA | 0.94190032 |
42 | EPHA2 | 0.93984384 |
43 | PRKD3 | 0.93238157 |
44 | MAPK12 | 0.90834707 |
45 | MAP2K4 | 0.90580618 |
46 | MAP2K3 | 0.89214015 |
47 | ROCK1 | 0.88014139 |
48 | WNK4 | 0.87601806 |
49 | CAMK2D | 0.85984948 |
50 | DDR2 | 0.84679223 |
51 | LIMK1 | 0.82804183 |
52 | SGK2 | 0.82734961 |
53 | TAOK1 | 0.82644742 |
54 | SIK1 | 0.79855814 |
55 | SGK223 | 0.77881037 |
56 | SGK494 | 0.77881037 |
57 | PRKAA2 | 0.77102838 |
58 | PTK6 | 0.76033580 |
59 | STK39 | 0.74930477 |
60 | MAPK13 | 0.74929074 |
61 | ILK | 0.73105254 |
62 | EPHB2 | 0.72126774 |
63 | MST1R | 0.71650077 |
64 | PAK6 | 0.69340101 |
65 | MAP3K5 | 0.66775485 |
66 | CASK | 0.65718323 |
67 | MTOR | 0.60673155 |
68 | MET | 0.59993769 |
69 | BMPR1B | 0.59700300 |
70 | MAP3K4 | 0.59470912 |
71 | AKT2 | 0.58927127 |
72 | WNK1 | 0.57322761 |
73 | GRK1 | 0.56695828 |
74 | ZAK | 0.56682763 |
75 | KSR2 | 0.56315449 |
76 | OXSR1 | 0.54736111 |
77 | GRK7 | 0.54269402 |
78 | CAMK4 | 0.54020562 |
79 | ERBB3 | 0.53431739 |
80 | DAPK2 | 0.53061286 |
81 | MARK1 | 0.51645629 |
82 | CAMK2B | 0.50426002 |
83 | MAP3K9 | 0.50055508 |
84 | MAP3K1 | 0.48499958 |
85 | CAMK1G | 0.48437250 |
86 | RET | 0.46871001 |
87 | MAPK4 | 0.46534384 |
88 | TRPM7 | 0.46485977 |
89 | CAMK2A | 0.46463656 |
90 | RPS6KA2 | 0.45480358 |
91 | TYRO3 | 0.45070481 |
92 | MAPK7 | 0.44506200 |
93 | ROCK2 | 0.43896143 |
94 | DYRK1B | 0.43593429 |
95 | CAMK1D | 0.41922048 |
96 | SGK3 | 0.40916996 |
97 | SGK1 | 0.39456386 |
98 | MAP2K6 | 0.39078136 |
99 | EPHB1 | 0.38330846 |
100 | PRKACB | 0.37956349 |
101 | EEF2K | 0.37574035 |
102 | NLK | 0.37209744 |
103 | PRKCH | 0.36709958 |
104 | PKN1 | 0.35450508 |
105 | PTK2 | 0.35239436 |
106 | PRKACA | 0.33996088 |
107 | MAP2K1 | 0.33906092 |
108 | CAMK2G | 0.33603568 |
109 | RPS6KA3 | 0.33006733 |
110 | PRKACG | 0.32956885 |
111 | CCNB1 | 0.32752619 |
112 | NEK9 | 0.30975984 |
113 | MAP3K6 | 0.30968891 |
114 | STK11 | 0.30723157 |
115 | NTRK3 | 0.30546217 |
116 | KSR1 | 0.30440080 |
117 | PTK2B | 0.30439022 |
118 | RPS6KA6 | 0.30145481 |
119 | ERN1 | 0.30110616 |
120 | FGFR1 | 0.29264477 |
121 | WNK3 | 0.29065451 |
122 | CAMK1 | 0.28673923 |
123 | MAPK11 | 0.28063547 |
124 | RPS6KB1 | 0.27977879 |
125 | ADRBK1 | 0.27667822 |
126 | RPS6KA1 | 0.26949666 |
127 | PDGFRB | 0.26811209 |
128 | PRKD2 | 0.26752462 |
129 | MARK2 | 0.26556763 |
130 | CDK12 | 0.25905509 |
131 | PRKCE | 0.24608256 |
132 | RPS6KB2 | 0.24587864 |
133 | PDPK1 | 0.23539954 |
134 | PRKG1 | 0.21795510 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.56643620 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.57098840 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.55017142 |
4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.52018334 |
5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.46363483 |
6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.92983029 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84573847 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30596283 |
9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.99107044 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97222886 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 1.78804536 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59982639 |
13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55017138 |
14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43527003 |
15 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.41019207 |
16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40764982 |
17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40302053 |
18 | Insulin resistance_Homo sapiens_hsa04931 | 1.36896710 |
19 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.34348322 |
20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.30429625 |
21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29024769 |
22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.28453590 |
23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.25342819 |
24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22365231 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21013701 |
26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18570373 |
27 | Tight junction_Homo sapiens_hsa04530 | 1.18241444 |
28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14006187 |
29 | Focal adhesion_Homo sapiens_hsa04510 | 1.13350571 |
30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10856961 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10208857 |
32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09432360 |
33 | Insulin secretion_Homo sapiens_hsa04911 | 1.07331997 |
34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06202898 |
35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.05713021 |
36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04468853 |
37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03510979 |
38 | ABC transporters_Homo sapiens_hsa02010 | 1.02950477 |
39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02665488 |
40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.00973410 |
41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99479152 |
42 | Adherens junction_Homo sapiens_hsa04520 | 0.98590682 |
43 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98455896 |
44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.97459747 |
45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96416611 |
46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93687459 |
47 | Phototransduction_Homo sapiens_hsa04744 | 0.93637911 |
48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92510656 |
49 | Lysine degradation_Homo sapiens_hsa00310 | 0.91210767 |
50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88738155 |
51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86747547 |
52 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86132962 |
53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85161235 |
54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84769400 |
55 | Renin secretion_Homo sapiens_hsa04924 | 0.84433522 |
56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83451754 |
57 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83397898 |
58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82920014 |
59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82538083 |
60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82462351 |
61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79643133 |
62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77957167 |
63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76386072 |
64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75733764 |
65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74721714 |
66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73861792 |
67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72966006 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69829390 |
69 | Gap junction_Homo sapiens_hsa04540 | 0.68668627 |
70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68377967 |
71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67349332 |
72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65513212 |
73 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65064189 |
74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64515341 |
75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.64412948 |
76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64376521 |
77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63108781 |
78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62770217 |
79 | Long-term depression_Homo sapiens_hsa04730 | 0.61500139 |
80 | Salivary secretion_Homo sapiens_hsa04970 | 0.61299716 |
81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60368934 |
82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60186331 |
83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60116787 |
84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60084429 |
85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59602216 |
86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58477752 |
87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58114317 |
88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58022341 |
89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57484264 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57252779 |
91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57064016 |
92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56732838 |
93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55909322 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55227196 |
95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54696720 |
96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54340942 |
97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54177104 |
98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54149011 |
99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52815601 |
100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52544722 |
101 | Melanogenesis_Homo sapiens_hsa04916 | 0.52476780 |
102 | Amoebiasis_Homo sapiens_hsa05146 | 0.52447846 |
103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51816072 |
104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51768027 |
105 | Peroxisome_Homo sapiens_hsa04146 | 0.51579452 |
106 | Bile secretion_Homo sapiens_hsa04976 | 0.51082387 |
107 | Morphine addiction_Homo sapiens_hsa05032 | 0.50363759 |
108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49109148 |
109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48996258 |
110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48408070 |
111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46515457 |
112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46447748 |
113 | Taste transduction_Homo sapiens_hsa04742 | 0.45077226 |
114 | Glioma_Homo sapiens_hsa05214 | 0.44945667 |
115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44803614 |
116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43900088 |
117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43071619 |
118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39785155 |
119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38892074 |
120 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37822893 |
121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37769540 |
122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36727083 |
123 | Axon guidance_Homo sapiens_hsa04360 | 0.35260530 |
124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35199172 |
125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33772508 |
126 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33398949 |